Clinical Trial Update: Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

The document reports an early-phase trial of adaptive Abiraterone therapy for metastatic castration-resistant prostate cancer and notes the study is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING